Sign in
NRXBF Stock Price, Chart, Stats & News
NurExone Biologic Inc.
Save
NurExone Biologic Inc. (NRXBF) does not currently pay a dividend.
–
Market cap
–
Current P/E
7.12x
Forward P/E
NRXBF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
Similar securities
Based on sector and market capitalization
Report issue